铁与血小板:微妙且未被充分认识的关系
本文综述铁与血小板之间关系的生理与病理机制。铁参与巨核细胞/红系祖细胞谱系定向及血小板线粒体能量产生;铁缺乏常伴血小板增多,严重缺铁性贫血也可出现血小板减少;炎症性铁隔离可先致血小板减少后反应性增多;遗传性铁过载除严重肝纤维化外未报道致血小板减少。
要点
- 铁缺乏常伴血小板增多,可能促进血管血栓形成。
- 严重缺铁性贫血也可出现血小板减少。
- 炎症性铁隔离可先致血小板减少,后反应性血小板增多。
核心结论
- 铁与血小板关系微妙且未被充分认识,铁状态异常可伴血小板数量改变,但机制复杂且常受基础血液病干扰。
研究设计与样本
- 本文为综述,围绕铁与血小板关系的生理与病理机制进行叙述性总结。
主要发现
- 铁与遗传因素共同引导巨核细胞/红系祖细胞向巨核细胞或红系祖细胞定向。
- 巨核细胞铁参与细胞机器,尤其血小板线粒体的能量产生。
- 总铁储备异常降低(主要因失血或十二指肠铁摄入减少)时可见血小板增多,可能促进血管血栓形成。
- 严重缺铁性贫血也可发生血小板减少。
- 炎症性铁隔离可伴早期血小板减少(因血小板消耗),随后反应性补充血小板池并可能血小板增多。
临床怎么用
- 临床遇血小板增多或减少时应关注铁状态,但需结合基础血液病综合判断,不宜单独归因于铁。
局限性
- 本文为综述,未提供原始研究数据或定量合并分析。
- 获得性铁过载中血小板改变难以单独归因于铁,因基础血液病干扰。
- 铁相关血小板功能改变仍有争议。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The role of iron in the formation and functioning of erythrocytes, and to a lesser degree of white blood cells, is well established, but the relationship between iron and platelets is less documented. Physiologically, iron plays an important role in hematopoiesis, including thrombopoiesis; iron levels direct, together with genetic factors, the lineage commitment of megakaryocytic/erythroid progenitors toward either megakaryocyte or erythroid progenitors. Megakaryocytic iron contributes to cellular machinery, especially energy production in platelet mitochondria. Thrombocytosis, possibly favoring vascular thrombosis, is a classical feature observed with abnormally low total body iron stores (mainly due to blood losses or decreased duodenal iron intake), but thrombocytopenia can also occur in severe iron deficiency anemia. Iron sequestration, as seen in inflammatory conditions, can be associated with early thrombocytopenia due to platelet consumption and followed by reactive replenishment of the platelet pool with possibility of thrombocytosis. Iron overload of genetic origin (hemochromatosis), despite expected mitochondrial damage related to ferroptosis, has not been reported to cause thrombocytopenia (except in case of high degree of hepatic fibrosis), and iron-related alteration of platelet function is still a matter of debate. In acquired iron overload (of transfusional and/or dyserythropoiesis origin), quantitative or qualitative platelet changes are difficult to attribute to iron alone due to the interference of the underlying hematological conditions; likewise, hematological improvement, including increased blood platelet counts, observed under iron oral chelation is likely to reflect mechanisms other than the sole beneficial impact of iron depletion.
引用
- Brissot E, Troadec MB, Loréal O, et al. Iron and platelets: A subtle, under-recognized relationship. Am J Hematol. 2021. PMID: 33844865. doi:10.1002/ajh.26189
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。